Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

February 01, 2013; Volume 83,Issue 2

Minireview

  • You have access
    Kainate Receptor Signaling in Pain Pathways
    Sonia K. Bhangoo and Geoffrey T. Swanson
    Molecular Pharmacology February 2013, 83 (2) 307-315; DOI: https://doi.org/10.1124/mol.112.081398

Accelerated Communication

  • You have access
    Sphingosine 1-Phosphate Receptor 1 (S1P1) Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist
    Stuart M. Cahalan, Pedro J. Gonzalez-Cabrera, Nhan Nguyen, Miguel Guerrero, Elizabeth A. George Cisar, Nora B. Leaf, Steven J. Brown, Edward Roberts and Hugh Rosen
    Molecular Pharmacology February 2013, 83 (2) 316-321; DOI: https://doi.org/10.1124/mol.112.082958

Articles

  • You have access
    CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity
    Gemma L. Baillie, James G. Horswill, Sharon Anavi-Goffer, Patricia H. Reggio, Daniele Bolognini, Mary E. Abood, Sean McAllister, Phillip G. Strange, Gary J. Stephens, Roger G. Pertwee and Ruth A. Ross
    Molecular Pharmacology February 2013, 83 (2) 322-338; DOI: https://doi.org/10.1124/mol.112.080879
  • You have access
    Enhanced Degradation of Dihydrofolate Reductase through Inhibition of NAD Kinase by Nicotinamide Analogs
    Yi-Ching Hsieh, Philip Tedeschi, Rialnat AdeBisi Lawal, Debabrata Banerjee, Kathleen Scotto, John E. Kerrigan, Kuo-Chieh Lee, Nadine Johnson-Farley, Joseph R. Bertino and Emine Ercikan Abali
    Molecular Pharmacology February 2013, 83 (2) 339-353; DOI: https://doi.org/10.1124/mol.112.080218
  • You have access
    Noncompetitive, Voltage-Dependent NMDA Receptor Antagonism by Hydrophobic Anions
    Andrew J. Linsenbardt, Mariangela Chisari, Andrew Yu, Hong-Jin Shu, Charles F. Zorumski and Steven Mennerick
    Molecular Pharmacology February 2013, 83 (2) 354-366; DOI: https://doi.org/10.1124/mol.112.081794
  • You have access
    Obtusilactone B from Machilus Thunbergii Targets Barrier-to-Autointegration Factor to Treat Cancer
    Wanil Kim, Ha-Na Lyu, Hyun-Sook Kwon, Ye Seul Kim, Kyung-Ha Lee, Do-Yeon Kim, Goutam Chakraborty, Kwan Yong Choi, Ho Sup Yoon and Kyong-Tai Kim
    Molecular Pharmacology February 2013, 83 (2) 367-376; DOI: https://doi.org/10.1124/mol.112.082578
  • You have access
    Induction of Multidrug Resistance Transporter ABCG2 by Prolactin in Human Breast Cancer Cells
    Alex Man Lai Wu, Pooja Dalvi, Xiaoli Lu, Mingdong Yang, David S. Riddick, Jason Matthews, Charles V. Clevenger, Douglas D. Ross, Patricia A. Harper and Shinya Ito
    Molecular Pharmacology February 2013, 83 (2) 377-388; DOI: https://doi.org/10.1124/mol.112.082362
  • You have access
    Functional Characterization of Three Mouse Formyl Peptide Receptors
    Hui-Qiong He, Dan Liao, Zhen-Guo Wang, Zhong-Li Wang, Hu-Chen Zhou, Ming-Wei Wang and Richard D. Ye
    Molecular Pharmacology February 2013, 83 (2) 389-398; DOI: https://doi.org/10.1124/mol.112.081315
  • You have access
    MicroRNA-145 Post-transcriptionally Regulates the Expression and Function of P-glycoprotein in Intestinal Epithelial Cells
    Kenji Ikemura, Misato Yamamoto, Saori Miyazaki, Hideki Mizutani, Takuya Iwamoto and Masahiro Okuda
    Molecular Pharmacology February 2013, 83 (2) 399-405; DOI: https://doi.org/10.1124/mol.112.081844
  • You have access
    Molecular Dissection of Lubeluzole Use–Dependent Block of Voltage-Gated Sodium Channels Discloses New Therapeutic Potentials
    Jean-François Desaphy, Roberta Carbonara, Teresa Costanza, Giovanni Lentini, Maria Maddalena Cavalluzzi, Claudio Bruno, Carlo Franchini and Diana Conte Camerino
    Molecular Pharmacology February 2013, 83 (2) 406-415; DOI: https://doi.org/10.1124/mol.112.080804
  • You have access
    Conformational Dynamics of Kir3.1/Kir3.2 Channel Activation Via δ-Opioid Receptors
    Melissa Richard-Lalonde, Karim Nagi, Nicolas Audet, Rory Sleno, Mohammad Amraei, Mireille Hogue, Gianfranco Balboni, Peter W. Schiller, Michel Bouvier, Terence E. Hébert and Graciela Pineyro
    Molecular Pharmacology February 2013, 83 (2) 416-428; DOI: https://doi.org/10.1124/mol.112.081950
  • You have access
    Canonical Transient Receptor Channel 5 (TRPC5) and TRPC1/4 Contribute to Seizure and Excitotoxicity by Distinct Cellular Mechanisms
    Kevin D. Phelan, U Thaung Shwe, Joel Abramowitz, Hong Wu, Sung W. Rhee, Matthew D. Howell, Paul E. Gottschall, Marc Freichel, Veit Flockerzi, Lutz Birnbaumer and Fang Zheng
    Molecular Pharmacology February 2013, 83 (2) 429-438; DOI: https://doi.org/10.1124/mol.112.082271
  • You have access
    Pyrimidine Salvage in Trypanosoma brucei Bloodstream Forms and the Trypanocidal Action of Halogenated Pyrimidines
    Juma A. M. Ali, Darren J. Creek, Karl Burgess, Harriet C. Allison, Mark C. Field, Pascal Mäser and Harry P. De Koning
    Molecular Pharmacology February 2013, 83 (2) 439-453; DOI: https://doi.org/10.1124/mol.112.082321
  • You have access
    Targeting the Metastasis Suppressor, NDRG1, Using Novel Iron Chelators: Regulation of Stress Fiber-Mediated Tumor Cell Migration via Modulation of the ROCK1/pMLC2 Signaling Pathway
    Jing Sun, Daohai Zhang, Ying Zheng, Qian Zhao, Minhua Zheng, Zaklina Kovacevic and Des R. Richardson
    Molecular Pharmacology February 2013, 83 (2) 454-469; DOI: https://doi.org/10.1124/mol.112.083097
  • You have access
    Mechanism of the Antiproliferative Activity of Some Naphthalene Diimide G-Quadruplex Ligands
    Sonja M. Hampel, Antonella Pepe, Karin M. Greulich-Bode, Sanjay V. Malhotra, Anthony P. Reszka, Sebastian Veith, Petra Boukamp and Stephen Neidle
    Molecular Pharmacology February 2013, 83 (2) 470-480; DOI: https://doi.org/10.1124/mol.112.081075
  • You have access
    An Allosteric Mechanism for Drug Block of the Human Cardiac Potassium Channel KCNQ1
    Tao Yang, Jarrod A. Smith, Brenda F. Leake, Charles R. Sanders, Jens Meiler and Dan M. Roden
    Molecular Pharmacology February 2013, 83 (2) 481-489; DOI: https://doi.org/10.1124/mol.112.081513
  • You have access
    Identification of Transporters Associated with Etoposide Sensitivity of Stomach Cancer Cell Lines and Methotrexate Sensitivity of Breast Cancer Cell Lines by Quantitative Targeted Absolute Proteomics
    Wataru Obuchi, Sumio Ohtsuki, Yasuo Uchida, Ken Ohmine, Takao Yamori and Tetsuya Terasaki
    Molecular Pharmacology February 2013, 83 (2) 490-500; DOI: https://doi.org/10.1124/mol.112.081083
  • You have access
    Bisphenol A Inhibits Voltage-Activated Ca2+ Channels in Vitro: Mechanisms and Structural Requirements
    André Deutschmann, Michael Hans, Rainer Meyer, Hanns Häberlein and Dieter Swandulla
    Molecular Pharmacology February 2013, 83 (2) 501-511; DOI: https://doi.org/10.1124/mol.112.081372
  • You have access
    Modulation of μ-Opioid Receptor Signaling by RGS19 in SH-SY5Y Cells
    Qin Wang and John R. Traynor
    Molecular Pharmacology February 2013, 83 (2) 512-520; DOI: https://doi.org/10.1124/mol.112.081992
  • You have access
    Allosteric Modulation of a Chemogenetically Modified G Protein-Coupled Receptor
    Alaa Abdul-Ridha, J. Robert Lane, Patrick M. Sexton, Meritxell Canals and Arthur Christopoulos
    Molecular Pharmacology February 2013, 83 (2) 521-530; DOI: https://doi.org/10.1124/mol.112.083006
  • You have access
    A Novel Semisynthetic Inhibitor of the FRB Domain of Mammalian Target of Rapamycin Blocks Proliferation and Triggers Apoptosis in Chemoresistant Prostate Cancer Cells
    Samy A. F. Morad, Maximilian Schmid, Berthold Büchele, Hans-Ullrich Siehl, Menna El Gafaary, Oleg Lunov, Tatiana Syrovets and Thomas Simmet
    Molecular Pharmacology February 2013, 83 (2) 531-541; DOI: https://doi.org/10.1124/mol.112.081349
  • You have access
    Apomorphine Is a Bimodal Modulator of TRPA1 Channels
    Anja Schulze, Beatrice Oehler, Nicole Urban, Michael Schaefer and Kerstin Hill
    Molecular Pharmacology February 2013, 83 (2) 542-551; DOI: https://doi.org/10.1124/mol.112.081976
  • You have access
    Ticlopidine, a Cholestatic Liver Injury-Inducible Drug, Causes Dysfunction of Bile Formation via Diminished Biliary Secretion of Phospholipids: Involvement of Biliary-Excreted Glutathione-Conjugated Ticlopidine Metabolites
    Takashi Yoshikado, Tappei Takada, Hideaki Yamamoto, Jeng Kae Tan, Kousei Ito, Tomofumi Santa and Hiroshi Suzuki
    Molecular Pharmacology February 2013, 83 (2) 552-562; DOI: https://doi.org/10.1124/mol.112.081752
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 83 (2)
Molecular Pharmacology
Vol. 83, Issue 2
1 Feb 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireview
  • Accelerated Communication
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics